Insider · CIK 0001635088
Roivant Sciences Ltd.
Files at ABUS (Arbutus Biopharma Corp), IMVT (Immunovant, Inc.). First filing Jan 15, 2025, latest Dec 12, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | IMVTbuy Immunovant, Inc. | $350M 16,666,666 shares | +17% | +99% from low-5% from high | |
| 46Moderate | IMVTbuy Immunovant, Inc. | $337M 16,845,010 shares | +21% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ABUS Arbutus Biopharma Corp | DDisposition to issuer Common Shares | -8,967,383 | $5.00 | $45M | 29,880,079 | 7 d ago |
| Dec 12, 2025 | IMVT Immunovant, Inc. | POpen-market purchase Common Stock, $0.0001 par value per share | +16,666,666 | $21.00 | $350M | 113,317,007 | Dec 12, 2025 |
| Jan 13, 2025 | IMVT Immunovant, Inc. | POpen-market purchase Common Stock, $0.0001 par value per share | +16,845,010 | $20.00 | $337M | 96,650,341 | Jan 15, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.